SCHEMBL6646244

SCHEMBL6646244

CCCC[C@H](NC(=O)OC1CCC(c2nc3ccccc3s2)C1)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.43
CTSK P43235 8/20 0.43
CTSV O60911 4/20 0.43
CTSL P07711 4/20 0.43
CTSS P25774 4/20 0.43
MAPT P10636 5/20 0.41
KMT2A Q03164 2/20 0.41
TP53 P04637 3/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C19 P33261 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
THRB P10828 1/20 0.40
MEN1 O00255 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
RECQL P46063 1/20 0.40
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40
NFKB1 P19838 1/20 0.40
STAT1 P42224 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6648974 0.72 CTSK (0.45) CTSKCTSLCTSSCYP1A2CYP2C19
SCHEMBL22777304 0.69 EPHX1 (0.51) CTSKCTSVCTSLCTSSSMN1; SMN2
SCHEMBL12166465 0.67 CTSK (0.62) CTSKCTSVCTSLCTSS
SCHEMBL2634138 0.65 MEN1 (0.61) GAAMAPTKMT2ATP53CYP1A2
SCHEMBL27780890 0.65 HDAC4 (0.54) CTSKCTSVCTSLCTSSSMN1; SMN2
SCHEMBL4908419 0.64 NPC1 (0.44) CTSKCTSLCTSSCYP1A2CYP2C19
SCHEMBL11436844 0.64 FAAH (0.55) CTSKCTSLCTSSCYP1A2
SCHEMBL9533470 0.64 KMT2A (0.77) GAAMAPTKMT2ATP53CYP1A2
SCHEMBL16545296 0.64 KMT2A (0.59) GAAMAPTKMT2ATP53CYP1A2
Hydrochloric Acid SCHEMBL4446986 0.64 HDAC4 (0.53) CTSKCTSVCTSLCTSSSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465862-A1 CYCLOALKYL KETOAMIDES DERIVATIVES USEFUL AS CATHEPSIN K INHIBITORS SmithKline Beecham Corporation (US) 2004-10-13 EP disclosed
WO-2003062192-A1 CYCLOALKYL KETOAMIDES DERIVATIVES USEFUL AS CATHEPSIN K INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2003-07-31 WO disclosed